BioCryst

$5.14
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.37 (+7.77%) Today
+$0.01 (+0.19%) As of 7:18 AM EST after-hours

Why Robinhood?

You can buy or sell BioCryst and other stocks, options, and ETFs commission-free!

About BCRX

BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. The listed name for BCRX is BioCryst Pharmaceuticals, Inc. Common Stock.

CEO
Jon P. Stonehouse
Employees
140
Headquarters
Durham, North Carolina
Founded
1986
Market Cap
905.78M
Price-Earnings Ratio
Dividend Yield
Average Volume
4.89M
High Today
$5.12
Low Today
$4.80
Open Price
$4.81
Volume
3.80M
52 Week High
$6.29
52 Week Low
$1.58

Collections

BCRX Earnings

-$0.34
-$0.23
-$0.11
$0.00
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Mar 4, Pre-Market

You May Also Like